Skip to main content

Month: March 2022

Apollo Commercial Real Estate Finance, Inc. to Present at Citi Global Property CEO Conference

NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) — Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI) today announced the Company will participate in the Citi Global Property CEO Conference. Stuart Rothstein, the Company’s Chief Executive Officer, is scheduled to present on March 8, 2022 at The Diplomat Beach Resort in Hollywood, Florida. The presentation is scheduled to begin at 10:30 am ET. Both presentations and question and answer periods will be broadcast live over the Internet and can be accessed by all interested parties through the Company’s website at www.apolloreit.com in the Stockholders section. There will be a replay available following the presentation which will remain on the Company’s website for thirty days. About Apollo Commercial Real Estate Finance, Inc. Apollo Commercial Real...

Continue reading

Points extends strategic collaboration with Marriott Bonvoy as exclusive global loyalty commerce technology provider; implements new Top-Up product

TORONTO, March 03, 2022 (GLOBE NEWSWIRE) — Global leader in powering loyalty commerce, Points (NASDAQ: PCOM) (TSX: PTS) is pleased to announce the extension of its relationship with Marriott Bonvoy as the program’s exclusive loyalty commerce technology provider of purchasing and gifting Marriott Bonvoy points. Points, through its loyalty solutions and data-driven marketing expertise, has proven to increase member engagement and generate additional revenue for Marriott Bonvoy over the course of their strategic collaboration, which began in 2006. The extension of the collaboration coincides with the introduction of a new solution for Marriott Bonvoy members, powered by Points. Fully integrated within Marriott’s direct booking channels, Top-Up makes it easy for Marriott Bonvoy members to confirm their next stay sooner using their...

Continue reading

Upcoming Webinar Discusses How Piezo Motion Products Are Disrupting the Motion Industry

Webinar will examine the company’s unique and affordable precision technology and the innovation behind its miniature motors LAKEWOOD RANCH, Fla., March 03, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Piezo Motion, a Brain Scientific (OTCQB:BRSF) company, will host a webinar on March 17 discussing how its miniature precision motors are disrupting the market by providing affordable piezoelectric technology. The webinar, led by Piezo Motion’s Solutions Engineer Sam Van Den Avond, will also analyze how Piezo Motion’s multifaceted rotary and linear motors are built with technology that provides a stable, accurate motor designed specifically for original equipment manufacturers (OEMs) that require ultimate speed, size and accuracy. “Our products are revolutionizing the precision motor market,” said Hassan Kotob, chairman and CEO...

Continue reading

Petros Pharmaceuticals to Present at the Q1 Investor Summit Conference

NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) — Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the Q1 Investor Summit Conference, which is being held virtually on March 8 – 9, 2022. Mr. Boctor will deliver his corporate presentation on Wednesday, March 9at 2:00 PM ET. Mr. Boctor will be available for one-on-one meetings throughout the conference. Click here to register: Q1 Investor Summit – INVESTOR REGISTRATION About Petros PharmaceuticalsPetros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men’s health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men’s health issues including,...

Continue reading

X4 Pharmaceuticals to Present at March Investor Conferences

BOSTON, March 03, 2022 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel CXCR4-targeted small molecule therapeutics to benefit patients with diseases of the immune system, today announced that management will participate in a panel at the 42nd Annual Cowen Healthcare Conference on Monday, March 7, 2022 and in a fireside chat at the 32nd Annual Oppenheimer Healthcare Conference on Tuesday, March 15, 2022. Details are as follows: Conference: 42nd Annual Cowen Healthcare Conference Format: Non-Malignant Hematology Panel Date: Monday, March 7, 2022Time: 12:50 PM ETPanel Webcast Link Conference: 32nd Annual Oppenheimer Healthcare Conference Format: Fireside Chat Date: Tuesday, March 15, 2022Time: 4:00 PM ETFireside Chat Webcast Link A live webcast of the panel and fireside...

Continue reading

Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended December 31, 2021 and Declaration of Distributions on Common Stock for the Months Ending April 30, May 31, and June 30, 2022

GREENWICH, Conn., March 03, 2022 (GLOBE NEWSWIRE) — Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQL) (NasdaqGS: OXSQZ) (NasdaqGS: OXSQG) (the “Company,” “we,” “us” or “our”) announced today its financial results and related information for the quarter ended December 31, 2021.On March 1, 2022, our Board of Directors declared the following distributions on our common stock:  Month Ending Record Date Payment Date Amount Per Share  April 30, 2022 April 15, 2022 April 29, 2022 $0.035  May 31, 2022 May 17, 2022 May 31, 2022 $0.035  June 30, 2022 June 16, 2022 June 30, 2022 $0.035Net asset value (“NAV”) per share as of December 31, 2021 stood at $4.92, compared with a NAV per share on September 30, 2021 of $5.03.Net investment income (“NII”), calculated in accordance with U.S. generally accepted accounting...

Continue reading

Genocea to Host Fourth Quarter 2021 Corporate Update Conference Call & Webcast

CAMBRIDGE, Mass., March 03, 2022 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation cancer immunotherapies, will host its fourth quarter 2021 financial results and corporate update conference call and live audio webcast on Thursday, March 10th at 8:30 a.m. E.T. Interested participants may access the conference call by dialing (844) 826-0619 (domestic) or (315) 625-6883 (international) and referring to conference ID number 1066689. To join the live webcast, please visit the presentation page of the investor relations section of the Genocea website at https://ir.genocea.com/events-presentations. A webcast replay will be available on the Genocea website beginning approximately two hours after the event and will be archived for 90 days. About Genocea Biosciences, Inc. Genocea’s...

Continue reading

The Children’s Place to Webcast Review of Fourth Quarter and Full Year 2021 Financial Results

SECAUCUS, N.J., March 03, 2022 (GLOBE NEWSWIRE) — The Children’s Place, Inc. (Nasdaq: PLCE) today announced that, in conjunction with the release of its fourth quarter and full year 2021 financial results, you are invited to listen to the Company’s conference call on Wednesday, March 9, 2022, beginning at 8:00 a.m. Eastern Time. To access the webcast, visit http://investor.childrensplace.com. An archive of the webcast can be accessed two hours after the live call has concluded. About The Children’s PlaceThe Children’s Place is the largest pure-play children’s specialty apparel retailer in North America. The Company designs, contracts to manufacture, sells at retail and wholesale, and licenses to sell fashionable, high-quality merchandise predominantly at value prices, primarily under the proprietary “The Children’s Place”, “Place”,...

Continue reading

Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2021 Financial Results and Provide Business Update

WATERTOWN, Mass., March 03, 2022 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated, precision immune tolerance platform, ImmTOR®, to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that it plans to host a conference call on Thursday, March 10, 2021, at 8:30 a.m. ET to discuss its financial results for the quarter and full-year ended December 31, 2021 and provide a business update. Individuals may participate in the live call via telephone by dialing (844) 845-4170 (domestic) or (412) 717-9621 (international) and may access a teleconference replay for one week by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and using confirmation code 10157869. Investors and the public can access the live...

Continue reading

Brascan Enters into Option Agreements to Acquire Mountain Pond, Birchy Lake and Miguel’s Lake Properties

Map The PropertiesVANCOUVER, British Columbia, March 03, 2022 (GLOBE NEWSWIRE) — Brascan Gold Inc. (CSE:BRAS), together with its subsidiary Baie Verte Resources Inc., (“Brascan” or the “Company”) is pleased to announce that they have entered into three separate option agreements (the “Agreements”) to acquire up to a 100% interest in the Mountain Pond property (the “Mountain Pond”), the Birchy Lake property (“Birchy Lake”) and the Miguel’s Lake property (“Miguel’s Lake” and, together with Mountain Pond and Birchy Lake, the “Properties”). The Properties are located in north and central Newfoundland. Property summary descriptions Mountain Pond: The Mountain Pond property comprises six adjacent licences covering 1,175 hectares and is located 6 kilometres northeast of the town of Springdale on the tide water of Halls Bay. Mountain...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.